| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
345,045,000 |
| Market
Cap: |
638.33(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$1.75 - $6 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Progressive Care, through its subsidiaries, is a health services organization and provider of prescription pharmaceuticals, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, the supply of prescription medications to long term care facilities, 340B services to charitable organizations, and health practice risk management. Co. also provides EnovaRx, which are FDA approved manufactured pain creams that are readily available with a prescription. In addition to these medications, Co. prepares psoriasis creams, wellness vitamins, weight loss formulations and holistic capsules.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
910,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$2,002,000 |
| Total People Bought |
0 |
0 |
0 |
2 |
| Total Buy Transactions |
0 |
0 |
0 |
2 |
| Total Shares Sold |
0 |
0 |
1,121,099 |
1,121,099 |
| Total Sell Value |
$0 |
$0 |
$4,955,521 |
$4,955,521 |
| Total People Sold |
0 |
0 |
2 |
2 |
| Total Sell Transactions |
0 |
0 |
2 |
2 |
| End Date |
2024-02-29 |
2023-11-28 |
2023-05-30 |
2022-05-30 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Weisberg Alan Jay |
Chief Executive Officer |
• • – |
2021-12-14 |
4 |
B |
$0.03 |
$8,326 |
D/D |
277,528 |
8,570,487 |
2.81 |
10% |
|
| Munnik Cecile |
CFO |
• – – |
2021-12-13 |
4/A |
B |
$0.03 |
$17,024 |
D/D |
532,000 |
1,000,000 |
2.74 |
- |
|
| Weisberg Alan Jay |
Chief Executive Officer |
• • – |
2021-12-13 |
4 |
B |
$0.03 |
$13,124 |
D/D |
437,451 |
8,292,959 |
2.81 |
19% |
|
| Munnik Cecile |
CFO |
• – – |
2021-12-13 |
4 |
B |
$0.03 |
$545 |
D/D |
17,024 |
532,000 |
2.66 |
19% |
|
| Munnik Cecile |
CFO |
• – – |
2021-12-10 |
4/A |
B |
$0.03 |
$14,976 |
D/D |
468,000 |
468,000 |
2.74 |
- |
|
| Weisberg Alan Jay |
Chief Executive Officer |
• • – |
2021-12-10 |
4 |
B |
$0.03 |
$2,962 |
D/D |
92,559 |
7,855,508 |
2.73 |
12% |
|
| Munnik Cecile |
CFO |
• – – |
2021-12-10 |
4 |
B |
$0.03 |
$478 |
D/D |
14,946 |
468,000 |
2.66 |
12% |
|
| Weisberg Alan Jay |
Chief Executive Officer |
• • – |
2021-12-09 |
4 |
B |
$0.03 |
$21,466 |
D/D |
692,462 |
7,762,949 |
2.81 |
6% |
|
| Hough Jervis |
Director |
– • – |
2017-08-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
9,717 |
|
- |
|
34 Records found
|
|
Page 2 of 2 |
|
|
0.10 (5.71%) 
